This is a non-core endpoint: only basic statistics are computed.
See its core counterpart CD2_INSITU_STOMACH_EXALLC for full statistics.
Carcinoma in situ of stomach
CD2_INSITU_STOMACH
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditions
|
518250 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
26 |
4. Check minimum number of eventsNone |
26 |
5. Include endpointsNone |
26 |
6. Filter based on genotype QC (FinnGen only) |
26 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
- Parent code in ICD-10
- D00
- Name in latin
- Carcinoma in situ recti
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of stomach
based on the number of shared cases.
Similar with more cases:
- Carcinoma in situ of stomach
- Carcinoma in situ of oral cavity, oesophagus and stomach
- Carcinoma in situ of oral cavity, oesophagus and stomach
- In situ neoplasms
- In situ neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
Not enough data for upset plot.
Not enough data for upset table.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 26 | 6 | 20 |
| Unadjusted period prevalence (%) | 0.01 | 0.00 | 0.01 |
| Median age at first event (years) | 75.60 | 76.39 | 75.37 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768797) Stomach Pathology biopsy report
16
21
18.21
12.99
4.9
1.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
15
34
9.06
7.38
4.3
2.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
19
52
10.74
7.19
4.2
2.2
—
—
—
0
0
(3002256) Pathology report gross observation
10
15
10.21
6.85
1.6
1.2
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
13
27
8.63
6.83
6.4
5.5
mmol/l
104.9
102.4
0.78
13
27
(4035726)
10
17
8.93
6.14
1.4
1.4
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
8
5
22.05
5.83
2.3
2.8
g/l
0.2
0.2
—
8
5
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
7
6
15.25
4.57
5.1
8.5
mmol/l
25.1
22.7
—
7
6
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
7
7
13.05
4.29
7.1
7.6
mmol/l
24.0
23.9
—
7
7
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
18
73
5.72
4.15
4.2
3.4
—
—
—
0
0
(3000991) Gas panel - Venous blood
8
12
9.04
4.02
6.5
5.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
16
62
5.11
3.99
3.2
2.2
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
16
62
5.11
3.99
7.5
5.7
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
18
79
5.12
3.86
6.3
6.3
mmol/l
1.2
1.2
1.33
18
66
(3014111) Lactate [Moles/volume] in Serum or Plasma
7
11
8.22
3.44
7.3
5.7
mmol/l
0.8
1.3
—
7
11
(3033658) Prothrombin time (PT) actual/Normal
12
41
4.58
3.39
8.3
3.5
%
84.5
80.1
0.20
12
41
(3024561) Albumin [Mass/volume] in Serum or Plasma
18
86
4.53
3.35
8.4
4.4
g/l
35.6
35.2
0.10
18
81
(3014007) Fractional oxyhemoglobin in Arterial blood
7
12
7.51
3.26
7.1
7.9
%
95.9
91.8
—
7
12
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
6
8
9.30
3.24
8.0
9.8
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
8
17
6.28
3.22
6.5
7.2
g/l
121.0
122.9
—
8
17
(3013826) Glucose [Moles/volume] in Serum or Plasma
20
110
4.52
3.09
9.9
4.9
mmol/l
7.5
6.8
0.95
20
103
(3018010) Neutrophils/100 leukocytes in Blood
17
81
4.15
3.07
9.6
7.2
%
56.6
59.6
0.35
17
74
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
19
106
3.92
2.75
13.1
4.9
umol/l
9.2
11.0
0.85
19
100
(3025941) Bacteria identified in Stool by Culture
6
11
6.71
2.71
1.2
1.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
5
7
8.48
2.67
1.8
1.9
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
5
7
8.48
2.67
1.0
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
5
7
8.48
2.67
1.0
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
5
7
8.48
2.67
1.0
1.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
8
23
4.54
2.52
2.3
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
5
8
7.40
2.48
1.8
1.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
8
24
4.34
2.42
6.5
5.9
mmol/l
-0.3
0.8
—
8
18
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
7
19
4.63
2.34
2.9
1.6
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
5
9
6.56
2.32
1.0
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
5
9
6.56
2.32
1.8
1.8
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
7
21
4.16
2.14
2.6
1.3
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
12
55
3.19
2.06
4.3
2.8
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
14
71
3.11
2.03
5.4
3.7
e6/l
7.0
50.0
—
9
50
(3023368) Bacteria identified in Blood by Culture
13
66
2.94
1.84
8.4
4.1
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
15
85
2.81
1.71
9.9
7.1
e9/l
0.0
0.0
—
10
78
(3001604) Monocytes [#/volume] in Blood
15
85
2.81
1.71
9.9
7.1
e9/l
0.7
0.6
—
10
77
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
20
139
2.89
1.63
17.9
7.0
u/l
98.5
78.2
1.15
20
129
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
15
87
2.71
1.61
3.0
2.4
pmol/l
94.6
84.8
—
8
50
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
13
76
2.42
1.30
4.4
3.0
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
5
22
2.56
1.08
2.8
2.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
8
46
2.06
0.93
1.5
2.3
mg/l
1.2
1.9
—
8
38
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
21
167
2.33
0.89
48.5
17.3
mg/l
25.5
27.7
0.18
21
138
(3019550) Sodium [Moles/volume] in Serum or Plasma
21
170
2.22
0.89
47.7
20.8
mmol/l
139.2
139.4
0.06
21
165
(3023103) Potassium [Moles/volume] in Serum or Plasma
21
171
2.18
0.88
48.0
20.6
mmol/l
4.0
4.0
0.10
21
165
(3044889) 12 lead EKG panel
16
116
1.99
0.83
5.1
4.7
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
7
41
1.96
0.78
2.4
2.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
5
25
2.23
0.77
2.8
2.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
21
172
2.14
0.73
27.6
14.4
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
21
176
2.00
0.72
52.7
20.0
umol/l
89.9
83.7
0.30
21
176
(40758558) Short blood count panel - Blood
8
48
1.96
0.72
12.9
8.2
—
—
—
0
0
(3015736) pH of Urine
11
76
1.78
0.61
3.6
4.5
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
21
181
1.83
0.57
61.7
24.5
e12/l
4.3
4.4
0.53
21
175
(3010813) Leukocytes [#/volume] in Blood
21
181
1.83
0.57
62.0
24.5
e9/l
14.2
7.1
0.53
21
174
(3007461) Platelets [#/volume] in Blood
21
181
1.83
0.57
61.7
24.5
e9/l
237.0
232.9
0.11
21
175
(3011397) Hemoglobin [Presence] in Urine by Test strip
7
44
1.80
0.56
1.7
4.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
7
48
1.62
0.52
3.1
3.5
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
9
66
1.55
0.46
2.1
2.4
u/l
182.3
428.1
—
9
60
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
6
42
1.55
0.39
1.3
1.9
mmol/l
1.2
1.2
—
6
33
(3041096) Erythrocytes [Presence] in Urine by Automated
7
52
1.47
0.35
5.6
4.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
5
41
1.27
0.23
1.0
1.5
—
—
—
0
0
(3020891) Body temperature
0
10
0.00
0.22
0.0
5.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
0
13
0.00
0.21
0.0
2.9
—
—
—
0
0
(3013512) EKG study
8
68
1.25
0.19
9.1
5.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
15
133
1.30
0.18
5.1
4.9
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
10
88
1.22
0.10
4.4
2.6
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
6
71
0.80
0.09
4.8
3.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
12
109
1.19
0.08
5.6
2.8
u/l
184.3
54.9
0.62
12
101
(3017817) Protein [Mass] in Urine collected for unspecified duration
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
7
71
0.98
0.00
5.4
4.7
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(44790049)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008898) HLA-B27 [Presence]
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.2
—
53.2
—
0
5
(4024509)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44790047)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
1.3
—
0
5
(44790048)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
0
7
0.00
0.00
0.0
7.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(44806118)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
0
8
0.00
-0.00
0.0
7.8
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
-0.00
0.0
1.6
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_STOMACH – Carcinoma in situ of stomach
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).